Glass Pharms
Glass Pharms is a UK-based company focused on cultivating medical cannabis for medicinal use. Their core business model revolves around supplying high-quality, UK-produced cannabis-based products for medicinal use (CBPMs) at a fair price. They differentiate themselves through a patent-pending continuous cultivation system that uses robotic automation and AI to simulate a growing year over 12-16 weeks, resulting in approximately 40% less power consumption than traditional indoor growing facilities. The company is committed to sustainability, being carbon negative by design through renewable energy, rainwater harvesting, and recycled cooling technologies, with no chemical pesticides used. Glass Pharms is licensed for third-party supply in the UK and is the first commercial grower of High-THC cannabis flower for lawful supply. Their cultivation is clinician-led, utilizing precision chemotypes with proven efficacy, and maintained with world-leading biosecurity and testing. British-based cultivation eliminates importation costs and supply chain issues, allowing for cost savings passed on to patients. The company emphasizes consistency in its end product through AI control of over 10 growing factors and utilizes energy-efficient glasshouse technology combined with Dutch horticultural innovation and British scientific expertise.
Glass Pharms
Glass Pharms is a UK-based company focused on cultivating medical cannabis for medicinal use. Their core business model revolves around supplying high-quality, UK-produced cannabis-based products for medicinal use (CBPMs) at a fair price. They differentiate themselves through a patent-pending continuous cultivation system that uses robotic automation and AI to simulate a growing year over 12-16 weeks, resulting in approximately 40% less power consumption than traditional indoor growing facilities. The company is committed to sustainability, being carbon negative by design through renewable energy, rainwater harvesting, and recycled cooling technologies, with no chemical pesticides used. Glass Pharms is licensed for third-party supply in the UK and is the first commercial grower of High-THC cannabis flower for lawful supply. Their cultivation is clinician-led, utilizing precision chemotypes with proven efficacy, and maintained with world-leading biosecurity and testing. British-based cultivation eliminates importation costs and supply chain issues, allowing for cost savings passed on to patients. The company emphasizes consistency in its end product through AI control of over 10 growing factors and utilizes energy-efficient glasshouse technology combined with Dutch horticultural innovation and British scientific expertise.